Valuation Abbott Laboratories Sao Paulo

Stocks

Market Closed - Sao Paulo 01:23:50 08/10/2026 am IST			5-day change	1st Jan Change
41.40 ^BRL	-16.78%		-3.02%	-27.82%

07/10	Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target	MT
05/10	Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,41,365	1,91,427	1,91,088	1,96,184	2,17,859	1,70,841	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-21.58%	-	-
Enterprise Value (EV) ¹	2,49,166	1,98,318	1,98,871	2,02,693	2,22,266	1,94,780	1,91,798	1,88,108
Change	-	-20.41%	0.28%	1.92%	9.66%	-12.37%	-1.53%	-1.92%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	28.9x	22.4x	19.6x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	3.57x	3.42x	3.24x
PEG	-	-36.9x	-2x	0x	-0.7x	-3.54x	0.8x	1.4x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	3.4x	3.13x	2.93x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	3.88x	3.52x	3.23x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	15x	13.3x	11.8x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	16.6x	14.7x	13.1x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	25.8x	21.5x	19.6x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.87%	4.65%	5.1%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.57	2.741	2.898
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.6%	2.78%	2.94%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.416	4.402	5.024
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	75.2%	62.3%	57.7%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	50,201	54,527	58,253
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	12,982	14,468	15,892
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,720	13,022	14,320
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,212	7,894	8,780
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	23,939	20,957	17,267
Reference price ²	140.74	109.79	110.07	113.11	125.29	98.73	98.73	98.73
Nbr of stocks (in thousands)	17,14,968	17,43,574	17,36,059	17,34,455	17,38,834	17,30,383	-	-
Announcement Date	26/01/22	25/01/23	24/01/24	22/01/25	22/01/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBOTT LABORATORIES	28.74x	3.86x	14.93x	2.62%	17TCr
MEDTRONIC PLC	18.62x	3.4x	12.17x	3.23%	11TCr
STRYKER CORPORATION	21.64x	4.26x	14.86x	1.29%	11TCr
ESSILORLUXOTTICA	25.96x	2.55x	10.26x	2.76%	7.6TCr
CENCORA, INC.	17.32x	0.2x	12.68x	0.75%	6.04TCr
HOYA CORPORATION	30.98x	7.66x	19.84x	1.29%	5.35TCr
BECTON, DICKINSON AND COMPANY	34.74x	3.37x	11.55x	2.18%	4.91TCr
IDEXX LABORATORIES, INC.	34.91x	8.68x	24.41x	-.--%	4.06TCr
DEXCOM, INC.	33.51x	5.87x	18.42x	-.--%	3.15TCr
Average	27.38x	4.43x	15.46x	1.57%	7.77TCr
Weighted average by Cap.	25.92x	4.02x	14.62x	1.97%